CNTG: ערך הפעילות העסקית בספרים centogene.com

Centogene N.V. (CNTG) is managed by specialized genetics experts who ensure reporting transparency and adherence to medical standards. This price chart reflects a market trend for the asset at 0.00. The business relies on the diagnosis of rare pathologies for clinics and pharmaceutical companies. Operational stability is supported by the neutral status of biomedicine, which minimizes the impact of global conflicts and sanction restrictions.

Centogene N.V. is developing a unique genetic data ecosystem, yet the restructuring of its debt profile makes the analysis of the company's balance sheet equity critically important. This indicator reflects the difference between total assets and all liabilities, allowing investors to assess the real value of net assets and the business's resilience against inflationary depreciation amid slowing operational growth.